. CYM-5478 does not protect cochlear neuroepithelial OC-k3 cells from cisplatin toxicity. (A) OC-k3 cells were treated with increasing concentrations in the presence of vehicle or 20 μM CYM-5478 for 24 hours prior to evaluation of viability by MTT assay. No significant difference was observed between EC50 values for vehicle and CYM-5478 groups. (B) OC-k3 cells were treated with vehicle, 20 μM cisplatin, or 20 μM cisplatin and 20 μM CYM-5478 for 24 hours prior to evaluation by CellROX assay. Cisplatin caused a ~25% increase in CellROX intensity relative to vehicle-treated controls. There was no significant difference between cisplatin alone and cisplatin + CYM-5478. N = 3, *p < 0.05, ns = not significant.
